Advances in Cancer Research
- George Vande Woude, Director, Van Andel Research Institute, Grand Rapids, MI, USA
- George Klein, Karolinska Insitutet, Stockholm, Sweden
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor antigen; Order, disorder, death: lessons from a superorganism; Control of differentiation in progression of epithelial tumors; Cancer vaccines: preclinical studies and novel strategies; Clinical results of vaccine therapy for cancer: learning from history for improving the future; Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell based cancer vaccines; NK cell receptors as tools in cancer immunotherapy; Innate immune recognition and suppression of tumors; Inhibitors of the HSP90 molecular chaperone: current status.View full description
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.
- Published: July 2006
- Imprint: ACADEMIC PRESS
- ISBN: 978-0-12-006695-7
Table of ContentsNY-ESO-1: Review of an Immunogenic Tumor Antigen.Order, Disorder, Death: Lessons from a Superorganism.Control of Differentiation in Progression of Epithelial Tumors.Cancer Vaccines: Preclinical Studies and Novel Strategies.Clinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future.Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8+ T-Cell Based Cancer Vaccines.NK Cell Receptors as Tools in Cancer Immunotherapy.Innate Immune Recognition and Suppression of Tumors.Inhibitors of the HSP90 Molecular Chaperone: Current Status.